Searched for
ZYDUS API UNIT
For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...
- Trump's 100% tariff on pharma will not impact generic makers, says Indian Pharma AllianceDonald Trump's proposed 100% tariffs on patented drugs from October 2025 are unlikely to immediately impact Indian pharma exports, which pr...
- Zydus Lifesciences shares in focus after Ahmedabad oncology injectable plant gets two FDA observationsZydus Lifesciences shares: The follow-up audit, conducted under Good Manufacturing Practices (GMP), took place from June 9 to June 18, 2025...
- Trump’s prescription drug price cuts unlikely to hit Indian pharma exports significantly: Crisil RatingsCrisil Ratings reports that President Trump's order to cut US drug prices will have a limited effect on Indian pharma. India's exports, mai...
- Exploring the Growth Potential of the Indian Pharmaceutical SectorThe Indian pharmaceutical sector is poised for significant growth, driven by favorable trade agreements and increasing global demand for ge...
- Zydus gets 6 observations from USFDA for API unitZydus Lifesciences on Saturday said the US health regulator has issued six observations after inspecting its Gujarat-based API manufacturin...
- Stocks in news: Zomato, Paytm, HAL, Som Distilleries, Adani Enterprises, TCSSensex and Nifty hit new highs. NCLAT directs NCLT to re-hear APL Apollo Tubes insolvency plea. Reliance Jio's tech collaboration with TM F...
- As Covid sales spike ebbs, what lies ahead for pharma companies?Indian pharmaceutical market flattened after the pandemic led to a massive upsurge in demand for drugs. The industry saw a rise in sales du...
- Stocks in the news: TCS, Tata Steel, Veranda Learning, Wipro and Tata MotorsTCS, Delta Corp, Birla Tyres, Kesoram Industries, Lasa Supergenerics, Elnet Technologies, Hathway Bhawani Cabletel and MPL Plastics are amo...
- Gilead donates remdesivir vials to govt to make up for delays on part of its partnersUS drugmaker Gilead Sciences on Tuesday donated 450,000 vials of the Covid-19 drug remdesivir to India, even as the delayed supplies from i...
- Ramping production of Remdesivir to meet demand: Pharma firmsA Zydus Cadila spokesperson said, "The current spike in COVID-19 cases has led to a higher demand of Remdesivir. We are currently producing...
- Government bans export of Remdesivir till Covid-19 situation improvesA state health department official said the state has more stock than that. Maharashtra is also planning to put a ban on the retail sale of...
- Government continuously working to improve ease of doing business in pharma sector: Minister"Under the leadership of Prime Minister Narendra Modi, the government continues to strive to improve the ease of doing business in the coun...
- Indian drug companies seek cure for Donald Trump’s 'Buy-American' planThe presidential order issued on August 6 called for federal agencies involved in the procurement of essential medicines, medical counterme...
- Zydus Cadila gets EIR from USFDA for Ankleshwar facilityThe company's active pharmaceutical ingredient (API) manufacturing facility located at Ankleshwar (unit 1), Gujarat has received an Establi...
- As going gets tough, pharma firms revisit past decisionsCompanies have rationalised field force and restructured product portfolio to up productivity.
- USFDA slaps ban on API supplied by India’s LaxachemThe USFDA has banned products of Laxachem Organics, a maker of active pharmaceutical ingredients, from US markets as part of the effort to ...
- Teva-Allergan deal a booster for Indian companiesTeva Pharmaceutical Industries’ $40.5-billion purchase of Allergan’s generics business may help Indian generic-drug makers acquire products
- Excise-free states lose biz on duty cutThe excise duty incentives announced in this year’s budget may have been welcomed by the industry, but it has spelt doom for excise free zo...
Load More
